Back to search

Peptide record

TPDB13692

Antibacterial Anticancer Toxicity standard
35 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB13692
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 35-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
IDTYSRKDDLDKKLLEVAKIIGRRLEKRHEYLAMK
Physicochemical Analysis
C188H319N55O54S1
NCQFPW
K
4246.00
9.99
11
7
14
+3
15.29
-0.897
103.14
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
2980
70.18
4
Residue Composition
number
2
A
4
R
0
N
4
D
0
C
3
E
0
Q
1
G
1
H
3
I
5
L
6
K
1
M
0
F
0
P
1
S
1
T
0
W
2
Y
1
V
Amino Acid Distribution
A: 2 R: 4 N: 0 D: 4 C: 0 E: 3 Q: 0 G: 1 H: 1 I: 3 L: 5 K: 6 M: 1 F: 0 P: 0 S: 1 T: 1 W: 0 Y: 2 V: 1
Chemical Descriptors
35
C188H319N55O54S1
4246.00
9.99
+3
15.29
-0.897
Evidence Records 1 records
Evidence 1 Activity

Activity

0% Hemolysis
Toxicity
8-256 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 8-256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation. | PLoS Negl Trop Dis | 2013